Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep457 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Lipid metabolism in patients with type 1 diabetes mellitus accompanied by ischemic heart disease

Artykbaeva Gulnora , Saatov Talat

Cardio-vascular disorders (CVD), ischemic heart disease (IHD) and myocardial infarction (MI) heading the line are the main cause of death among patients with diabetes mellitus (DM). DM has been proved to be an essential risk factor for IHD and MI to be instrumental in regarding all patients as belonging to the CVD high risk group. Dysfunction of adipocytes, insulin resistance, hyperinsulinemia, hyperglycemia and dyslipidemia seen in DM are the triggers for the cascade of hemod...

ea0090ep468 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Lipid metabolism in patients type 1 and type 2 diabetes mellitus combined with Ischemic heart disease

Artykbaeva Gulnora , Saatov Talat

Diabetes mellitus with characteristic high blood serum glucose may cause various disorders, including damages to blood vessels. Both type 1 and type 2 DM increase the IHD risk by 4-6 times. The work was initiated to study parameters of lipid metabolism in patients with the IHD-combined type 1 and type 2 DM.Materials and Methods: We examined concentrations of total lipids, triglycerides (TG), total cholesterol (TC) and high density lipoprotein cholesterol...

ea0070aep448 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Phospholipid metabolism in patients with type I and 2 diabetes mellitus

Artykbaeva Gulnora , Saatov Talat

The onset of diabetes mellitus caused by insulin deficiency and insulin resistance is simultaneous with the onset of disorders in lipid and carbohydrate metabolism. Phospholipids are subjected to major alterations in the lipid structures. The data on composition of phospholipids in diabetes mellitus are discordant. The work was initiated to study concentrations of phospholipids in blood of patients with type 1 and type 2 diabetes mellitus. 24 patients with type 1 DM (T1DM) and...

ea0099ep166 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Blood phospholipid profile in patients with type 1 diabetes mellitus combined with ischemic heart disease

Artykbaeva Gulnora , Saatov Talat

For quite a long period of time, diabetes mellitus (DM) has been considered as the carbohydrate metabolism disorder; to maintain blood glucose normal was believed to be the only mission of insulin. By now, findings from many studies have proved that DM is accompanied by the complex disorder of metabolism not only for carbohydrates, but also for lipids and proteins. Atherosclerotic injury of large vessels and ketoacidosis are known to be the main DM complications. The work was ...

ea0099ep1046 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Effect of hypoglycemics on lipid parameters in patients with diabetes mellitus and ischemic heart disease

Artykbaeva Gulnora , Saatov Talat

2 type diabetes mellitus (2DM) determines high risk of cardio-vascular disorders and pathologies of cardio-vascular system, to name arterial hypertension, ischemic heart disease and hypercholesterolemia. In addition, prolonged insufficient DM compensation results in onset of macrovascular complications eventually causing adverse effects. UKPDS findings demonstrated that intense glycemia control significantly reduced the risk of microvascular diabetic complications, but produce...

ea0063p572 | Diabetes, Obesity and Metabolism 2 | ECE2019

Erythrocytes membrane plasmalogens level in Diabetes Mellitus depends from Arterial Hypertension and nephropathy

Saatov Talat , Akhrarova Nilufar , Shamansurova Zulaykho

Introduction: Metabolic disturbances at the Diabetes Mellitus (DM) leads to structural and functional abnormalities of the cell plasma membrane due to changes in the lipid content and composition, especially phospholipids. Plasmalogens are unique group of phospholipids with alcohol and ether bounds, presented in a few papers. We hypothesis their involvement into pathogenesis of DM.Material and methods: We studied the content of Plasmalogens in blood plas...

ea0073aep172 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

NaKATPase activity regulated by glycemia level in patients with DM

Shamansurova Zulaykho , Saatov Talat , Tsoy Arina

IntroductionNaKATPase is membrane bound enzyme, necessary for maintenance of the cell potential and volume, ion flow, neuronal signal transduction. Previous studies showed decreasing of its activity in patients with diabetes mellitus (DM). Mechanisms regulated enzymes activity in DM is not clear yet. We proposed that glycemia is a main regulator of NaKATPase activity in erythrocytes at the DM.Material and methods<p class="abste...

ea0090p493 | Thyroid | ECE2023

Role of thyroid hormones in the development of neurodegeneration in rats

Mustafakulov Muhammadjon , Saatov Talat , Ishankhodjaev Takhir , Yalalova Ilmira , Shamansurova Zulaykho

Introduction: Neurodegeneration is one of the most common condition accompanied Diabetes Mellitus, Parkinson’s and Alzheimer’s diseases. Although its mechanisms intensively studied for many years, some questions of pathogenesis remain unclear. The aim of the study was investigate the effects of thyroid hormones and some neurotransmitters on the cerebral cortex of rats with experimental neurodegeneration. Materials and methods: Series of experim...

ea0090ep243 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Study on histomorphological features of the brain tissues in animals with experimental diabetes mellitus

Saatov Talat , Artykbaeva Gulnora , Ibragimova Elvira , Ishanhodjaev Tokhir

For quite a long time, the brain has been considered as an insulin independent organ capable of utilizing glucose without participation of insulin. Today, insulin is thought to be not only a regulator of glucose transport and metabolism, but also as a modulator of some processes, including neuronal excitability, proliferation and differentiation of progenitor cells, synaptic plasticity, memory formation, secreting of neurotransmitters and apoptosis. The work was initiated to c...

ea0063p564 | Diabetes, Obesity and Metabolism 2 | ECE2019

Erythrocytes glucose uptake increases in rats with experimental induced obesity, diabetes and hyperinsulinemia

Shamansurova Zulaykho , Alieva Anna , Tashmanova Akmaral , Saatov Talat

Introduction: As were previously shown the erythrocytes glucose uptake is impaired in patients with the Diabetes Mellitus, obesity and polycystic ovarian syndrome due to insulin resistance. For further, study whether the erythrocytes glucose uptake will be impaired in rats with experimental metabolic syndrome were observed gradually.Material and methods: The 40 adult white male rats separated into 4 groups. In 10 rats diabetes were induced by injection o...